LOS ANGELES--(BUSINESS WIRE)--Orthopaedic Institute for Children has joined with other leading healthcare providers throughout California to urge defeat of Governor Brown’s proposed elimination of the existing Discount Drug Program for Medi-Cal patients.
“Elimination of this benefit will severely compromise the ability of California’s most vulnerable patients to receive the treatments and services they need to live and thrive,” said OIC Chief Operating Officer Debra Mathias. “Patients with chronic and debilitating illnesses will suffer greatly under this proposal, which is why we strongly urge members of the Senate Budget Subcommittee on Health to oppose this measure.”
The 340B program in question provides significant reductions to the cost of outpatient medications and allows those resources to be exclusively reinvested by California’s 11 hemophilia treatment centers (HTCs), which serve more than 9,000 patients each year. The specialized care provided at these centers has resulted in a 60 percent reduction in patient morbidity as well as improved patient quality of life through reduced bleed-related hospitalizations, fewer days lost from school and work, and increased employment. It has also translated to lower short- and long-term costs to the state as patients receive timely and appropriate care for their complex conditions.
“This 340B program has resulted in better patient care and improved outcomes for patients living with chronic and debilitating blood disorders,” said Mathias. “We hope the Senate will reject this damaging proposal so we can continue our commitment to bettering the health and well-being of the most vulnerable among us.”
OIC’s HTC provides multi-specialty care to patients of any age or origin who are suffering from hemophilia and other coagulation disorders as well as adults and adolescents who have acquired blood-borne infections – including chronic hepatitis and HIV infection – through prior treatment with blood products. It is the largest HTC for adults (ages 14+) in Southern California. The center is staffed by a world-renowned, multidisciplinary team of doctors, nurses, social workers, physical therapists and pharmacists – all of whom are dedicated to providing personalized treatment and care to individuals suffering from hemophilia and other bleeding and clotting disorders.
About Orthopaedic Institute for Children
Orthopaedic Institute for Children (OIC) was founded in 1911 as Los Angeles Orthopaedic Hospital. Focused solely on musculoskeletal conditions in children, OIC receives nearly 70,000 patient visits each year. In alliance with UCLA Health and with the support of the OIC Foundation, we advance pediatric orthopaedics worldwide through outstanding patient care, medical education and research. Our locations in downtown Los Angeles, Santa Monica, Westwood and Calexico treat the full spectrum of pediatric orthopaedic disorders and injuries. For more information, visit us at ortho-institute.org.